These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1679438)

  • 1. Restriction fragment length polymorphism analysis of azole-resistant and azole-susceptible Candida albicans strains.
    Pearce MA; Howell SA
    J Clin Microbiol; 1991 Jul; 29(7):1364-7. PubMed ID: 1679438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole-sensitive and -resistant strains.
    Howell SA; Mallet AI; Noble WC
    J Appl Bacteriol; 1990 Nov; 69(5):692-6. PubMed ID: 2276986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance mechanisms in clinical isolates of Candida albicans.
    White TC; Holleman S; Dy F; Mirels LF; Stevens DA
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1704-13. PubMed ID: 12019079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates.
    Coste A; Selmecki A; Forche A; Diogo D; Bougnoux ME; d'Enfert C; Berman J; Sanglard D
    Eukaryot Cell; 2007 Oct; 6(10):1889-904. PubMed ID: 17693596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
    White TC; Pfaller MA; Rinaldi MG; Smith J; Redding SW
    Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of C-5 Sterol Desaturase Activity in
    Luna-Tapia A; Butts A; Palmer GE
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates.
    Strzelczyk JK; Slemp-Migiel A; Rother M; Gołąbek K; Wiczkowski A
    Acta Biochim Pol; 2013; 60(4):547-52. PubMed ID: 24340302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-identity and authentication of two major reference strains of Candida albicans.
    MacKenzie DW; Odds FC
    J Med Vet Mycol; 1991; 29(4):255-61. PubMed ID: 1682436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of azole resistance in the Darlington strain of Candida albicans.
    Kakeya H; Miyazaki Y; Miyazaki H; Nyswaner K; Grimberg B; Bennett JE
    Antimicrob Agents Chemother; 2000 Nov; 44(11):2985-90. PubMed ID: 11036010
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Nishimoto AT; Wiederhold NP; Flowers SA; Zhang Q; Kelly SL; Morschhäuser J; Yates CM; Hoekstra WJ; Schotzinger RJ; Garvey EP; Rogers PD
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.
    Marr KA; Lyons CN; Ha K; Rustad TR; White TC
    Antimicrob Agents Chemother; 2001 Jan; 45(1):52-9. PubMed ID: 11120944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
    Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
    Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans.
    Favre B; Didmon M; Ryder NS
    Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2715-25. PubMed ID: 10537193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDR16-mediated azole resistance in Candida albicans.
    Saidane S; Weber S; De Deken X; St-Germain G; Raymond M
    Mol Microbiol; 2006 Jun; 60(6):1546-62. PubMed ID: 16796687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistant mechanisms of Candida albicans to fluconazole.
    Wang W; Li R; Wang D; Li S; Zhu L; Wang X; Wan Z; Zhai W
    Chin Med J (Engl); 1999 May; 112(5):466-71. PubMed ID: 11593521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.
    Maesaki S; Marichal P; Hossain MA; Sanglard D; Vanden Bossche H; Kohno S
    J Antimicrob Chemother; 1998 Dec; 42(6):747-53. PubMed ID: 10052898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates.
    Dromer F; Improvisi L; Dupont B; Eliaszewicz M; Pialoux G; Fournier S; Feuillie V
    AIDS; 1997 Jul; 11(9):1095-101. PubMed ID: 9233455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of human P-glycoprotein-like molecule in azole-resistant Candida albicans from HIV+ patients.
    Stringaro A; Molinari A; Calcabrini A; Arancia G; Ceddia PG; Cianfriglia M; Poloni F; Mondello F; Angiolella L; De Bernardis F; Cassone A
    Microb Drug Resist; 2002; 8(3):235-44. PubMed ID: 12363014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans.
    Xiang MJ; Liu JY; Ni PH; Wang S; Shi C; Wei B; Ni YX; Ge HL
    FEMS Yeast Res; 2013 Jun; 13(4):386-93. PubMed ID: 23480635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.